In the past week, LQDA stock has gone up by 2.57%, with a monthly decline of -29.08% and a quarterly plunge of -0.93%. The volatility ratio for the week is 5.00%, and the volatility levels for the last 30 days are 5.78% for Liquidia Corp The simple moving average for the last 20 days is -5.57% for LQDA’s stock, with a simple moving average of -3.35% for the last 200 days.
Is It Worth Investing in Liquidia Corp (NASDAQ: LQDA) Right Now?
Moreover, the 36-month beta value for LQDA is 0.11. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 1 as “sell.”
The public float for LQDA is 68.81M and currently, short sellers hold a 28.34% of that float. On July 09, 2025, LQDA’s average trading volume was 2.08M shares.
LQDA) stock’s latest price update
Liquidia Corp (NASDAQ: LQDA) has experienced a rise in its stock price by 2.65% compared to its previous closing price of $12.45. However, the company has seen a gain of 2.57% in its stock price over the last five trading days. seekingalpha.com reported 2025-06-30 that Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several billion dollars. Market sentiment remains skeptical, pricing in limited Yutrepia success despite a large addressable market and competitor United Therapeutics’ strong sales. Valuation scenarios suggest substantial upside if LQDA captures meaningful market share, but capital raises and medium-term competition could weigh on expectations.
Analysts’ Opinion of LQDA
Many brokerage firms have already submitted their reports for LQDA stocks, with Oppenheimer repeating the rating for LQDA by listing it as a “Underperform.” The predicted price for LQDA in the upcoming period, according to Oppenheimer is $13 based on the research report published on May 19, 2025 of the current year 2025.
Wells Fargo, on the other hand, stated in their research note that they expect to see LQDA reach a price target of $20. The rating they have provided for LQDA stocks is “Overweight” according to the report published on December 20th, 2024.
LQDA Trading at -14.93% from the 50-Day Moving Average
After a stumble in the market that brought LQDA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.16% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LQDA starting from Schundler Russell, who sale 8,460 shares at the price of $16.97 back on Jun 04 ’25. After this action, Schundler Russell now owns 582,054 shares of Liquidia Corp, valued at $143,566 using the latest closing price.
Moomaw Scott, the Chief Commercial Officer of Liquidia Corp, sale 6,656 shares at $16.97 during a trade that took place back on Jun 04 ’25, which means that Moomaw Scott is holding 224,921 shares at $112,952 based on the most recent closing price.
Stock Fundamentals for LQDA
Current profitability levels for the company are sitting at:
- -9.04 for the present operating margin
- 0.58 for the gross margin
The net margin for Liquidia Corp stands at -9.04. The total capital return value is set at -0.77. Equity return is now at value -188.03, with -60.22 for asset returns.
Based on Liquidia Corp (LQDA), the company’s capital structure generated 0.75 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 2.97. The interest coverage ratio of the stock is -8.74.
Currently, EBITDA for the company is -115.71 million with net debt to EBITDA at 0.2. When we switch over and look at the enterprise to sales, we see a ratio of 75.68. The receivables turnover for the company is 11.34for trailing twelve months and the total asset turnover is 0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.93.
Conclusion
To wrap up, the performance of Liquidia Corp (LQDA) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
